<DOC>
	<DOCNO>NCT02482077</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , efficacy Sofosbuvir contain regimen treatment-naive treatment-experienced patient HCV genotypes 2 infection .</brief_summary>
	<brief_title>Sofosbuvir Containing Regimens Treatment Chronic HCV GT2 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>1 . Age equal great 18 year , chronic genotype 2 HCV infection ; 2 . Documented HCV treatmentnaïve treatmentexperienced subject fail previous PEG+RBV regimen ; 3 . HCV RNA &gt; 10,000 IU/mL Screening ; 4 . Screening laboratory value within define threshold 5 . Use two effective contraception method female childbearing potential sexually active male 1 . Pregnant nursing female male pregnant female partner ; 2 . HIV chronic hepatitis B virus ( HBV ) infection ; 3 . Hematologic biochemical parameter Screening outside protocolspecified requirement ; 4 . Active recent history ( ≤ 1 year ) drug alcohol abuse ; 5 . Hepatocellular carcinoma malignancy ( exception certain resolve skin cancer ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>